Skip to main content

Advertisement

SpringerLink
Log in

Surgical treatment of gastrointestinal neuroendocrine tumors

  • Review Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are uncommon but clinically challenging and fascinating tumors. GEP-NETs present as either functional or as nonfunctional tumors. Functional tumors are commonly associated with a specific hormonal syndrome directly related to a hormone secreted by the tumor, like gastrinomas with a Zollinger–Ellison syndrome or carcinoid syndrome in patients with neuroendocrine tumors (NET) of the ileum. Nonfunctional tumors do not secrete a hormone resulting in a clinical syndrome.

Methods

The natural course of GEP-NETs is highly variable. Small, benign neoplasms such as 90% of all insulinomas or gastric endocrine tumors type 1 are readily curable by surgical resection; however, most other GEP-NETs have a much less favorable prognosis. Patients with completely resected tumors generally have a good prognosis, and an aggressive surgical approach in patients with advanced disease may also prolong survival.

Conclusions

This review focuses on the current standards of surgical treatment of gastric endocrine tumors, NETs of the pancreas (PNET) and NETs of the ileum. Although the evidence level is low in many instances due to the lack of randomized controlled trials, important treatment recommendations can be given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Niederle MB, Hackl M, Kaserer K, Niederle B (2010) Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 17:909–918

    Article  PubMed  Google Scholar 

  2. Klöppel G, Scherübl H (2010) Neuroendocrine tumors of the stomach. Risk stratification and therapy. Pathologe 31:182–187

    Article  PubMed  Google Scholar 

  3. Akerström G, Hellman P (2007) Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21:87–109

    Article  PubMed  Google Scholar 

  4. Borch K, Ahrén B, Ahlman H et al (2005) Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 242:64–73

    Article  PubMed  Google Scholar 

  5. Ichikawa J, Tanabe S, Koizumi W et al (2003) Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 35:203–206

    Article  PubMed  CAS  Google Scholar 

  6. Delle Fave G, Capurso G, Milione M, Panzuto F (2005) Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 19:659–673

    Article  PubMed  CAS  Google Scholar 

  7. Campana D, Nori F, Pezzilli R, Piscitelli L, Santini D, Brocchi E, Corinaldesi R, Tomassetti P (2008) Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer 15:337–342

    Article  PubMed  CAS  Google Scholar 

  8. Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 84:158–164

    Article  PubMed  CAS  Google Scholar 

  9. Rindi G, Bordi C, Rappel S et al (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20:168–172

    Article  PubMed  CAS  Google Scholar 

  10. Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135:1469–1492

    Article  PubMed  CAS  Google Scholar 

  11. Öberg K, Eriksson B (2005) Endocrine tumors of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781

    Article  PubMed  Google Scholar 

  12. Komminoth P, Perren A, Oberg K, Rindi G, Kloppel G, Heitz PU (2004) (2004) Gastrinoma. In: DeLellis RA, Lloyd R, Heitz PU, Eng C (eds) Pathology and genetics of tumors of the endocrine organs. WHO Classification of Tumors. IARC Press, Lyon, pp 191–194

    Google Scholar 

  13. Solcia E, Klöppel G, Sobin LH (2000) Histological typing of endocrine tumors. WHO International Histological Classification of Tumors, 2nd edn. Springer, Berlin, pp 56–70

    Google Scholar 

  14. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401

    Article  PubMed  CAS  Google Scholar 

  15. Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265

    Article  PubMed  Google Scholar 

  16. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, Kwekkeboom DJ, Oberg K, Eriksson B, Wiedenmann B, Rindi G, O'Toole D, Ferone D, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 84:183–188

    Article  PubMed  Google Scholar 

  17. Danforth DNJ et al (1984) Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 96:1027–1036

    PubMed  Google Scholar 

  18. Jensen RT, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V, Scarpa A, Sundin A, Perren A, Gross D, O'Connor JM, Pauwels S, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Gastrinoma (duodenal and pancreatic). Neuroendocrinology 84:173–182

    Article  PubMed  CAS  Google Scholar 

  19. Weber HC et al (1995) Determinants of metastatic rate and survival in patients with Zollinger–Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637–1649

    Article  PubMed  CAS  Google Scholar 

  20. Yu F, Venzon DJ, Serrano J et al (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger–Ellison syndrome. J Clin Oncol 17:615–630

    PubMed  CAS  Google Scholar 

  21. Hoffmann KM, Furukawa M, Jensen RT (2005) Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 19:675–697

    Article  PubMed  CAS  Google Scholar 

  22. O'Toole D, Salazar R, Falconi M, Kaltsas G, Couvelard A, de Herder WW, Hyrdel R, Nikou G, Krenning E, Vullierme MP, Caplin M, Jensen R, Eriksson B, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Rare functioning pancreatic endocrine tumors. Neuroendocrinology 84:189–195

    Article  PubMed  Google Scholar 

  23. Nilsson O, Van Cutsem E, Delle Fave G, Yao JC, Pavel ME, McNicol AM, Sevilla Garcia MI, Knapp WH, Keleştimur F, Sauvanet A, Pauwels S, Kwekkeboom DJ, Caplin M, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 84:212–215

    Article  PubMed  CAS  Google Scholar 

  24. Fendrich V, Langer P, Celik I et al (2006) An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 244:845–851, discussion 852–853

    Article  PubMed  Google Scholar 

  25. Bartsch DK, Fendrich V, Langer P et al (2005) Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 242:757–764, discussion 764–766

    Article  PubMed  Google Scholar 

  26. Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, Gloor B, Martius F, Maecke H, Reubi JC (2009) Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab 94:4398–4405

    Article  PubMed  CAS  Google Scholar 

  27. Fendrich V, Habbe N, Celik I et al (2007) Operative Therapie und Langzeitüberleben bei neuroendokrinen Pankreastumoren Erfahrungen bei 144 Patienten. Dtsch Med Wochenschr 2:195–200

    Article  Google Scholar 

  28. Rothmund M, Angelini L, Brunt M et al (1990) Surgery for benign insulinoma: an international review. World J Surg 14:393–399

    Article  PubMed  CAS  Google Scholar 

  29. Hirshberg B et al (2002) Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg 194:761–764

    Article  PubMed  Google Scholar 

  30. Thompson NW (1998) Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Clin N Am 7:881–891

    CAS  Google Scholar 

  31. Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger–Ellison syndrome. N Engl J Med 341:635–644

    Article  PubMed  CAS  Google Scholar 

  32. Norton JA, Jensen RT (2004) Resolved and unresolved controversies in the surgical management of patients with Zollinger–Ellison syndrome. Ann Surg 240:757–773

    Article  PubMed  Google Scholar 

  33. Norton JA, Fraker DL, Alexander HR et al (2006) Surgery increases survival in patients with gastrinoma. Ann Surg 244:410–419

    PubMed  Google Scholar 

  34. Steinmüller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, Delle Fave GF, O'Toole D, Frascati Consensus Conference Participants (2008) Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87:47–62

    Article  PubMed  Google Scholar 

  35. Fendrich V, Langer P, Waldmann J et al (2007) The management of sporadic and MEN-1-gastrinomas. Br J Surg 94:1331–1341

    Article  PubMed  CAS  Google Scholar 

  36. Zogakis TG, Gibril F, Libutti SK et al (2003) Management and outcome of patients with sporadic gastrinoma arising in the duodenum. Ann Surg 238:42–48

    Article  PubMed  Google Scholar 

  37. Mignon M, Ruszniewski P, Podevin P et al (1993) Current approach to the management of a gastrinoma and insulinoma in adults with multiple endocrine neoplasia I. World J Surg 17:489–495

    Article  PubMed  CAS  Google Scholar 

  38. Tonelli F, Fratini G, Nesi G et al (2006) Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 244:61–70

    Article  PubMed  Google Scholar 

  39. Imamura M, Komoto I, Doi R et al (2005) New pancreas—preserving total duodenectomy technique. World J Surg 29:203–207

    Article  PubMed  Google Scholar 

  40. Hellman P, Andersson M, Rastad J et al (2000) Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 24:1353–1360

    Article  PubMed  CAS  Google Scholar 

  41. Norton JA, Kivlen M, Li M et al (2003) Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 138:859–866

    Article  PubMed  Google Scholar 

  42. Fendrich V, Waldmann J, Bartsch DK et al (2009) Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 6:419–428

    Article  PubMed  Google Scholar 

  43. Kouvaraki MA, Solorzano CC, Shapiro SE et al (2005) Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89:170–185

    Article  PubMed  Google Scholar 

  44. Bartsch DK, Schilling T, Ramaswamy A et al (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24:1418–1424

    Article  PubMed  CAS  Google Scholar 

  45. Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Pape UF, Ricke J, Goretzki PE, Wildi S, Steinmuller T, Oberg K, Scoazec JY, Frascati Consensus Conference Participants, European Neuroendocrine Tumor Society (2006) Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 84:196–211

    Article  PubMed  CAS  Google Scholar 

  46. Solorzano CC, Lee JE, Pisters PTW et al (2001) Nonfunctioning islet cell carcinoma of the pancreas: Survival results in a contemporary series of 163 patients. Surgery 130:1078–1085

    Article  PubMed  CAS  Google Scholar 

  47. Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH, Rothmund M, Langer P (2009) Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Surg 33:1208–1218

    Article  PubMed  Google Scholar 

  48. Skogseid B et al (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281–287

    Article  PubMed  CAS  Google Scholar 

  49. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B, European Neuroendocrine Tumour Society (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80:394–424

    Article  PubMed  Google Scholar 

  50. Kann PH, Balakina E, Ivan D et al (2006) Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Endocr Relat Cancer 13:1195–1202

    Article  PubMed  CAS  Google Scholar 

  51. Thomas-Marques L, Murat A, Delemer B et al (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266–273

    Article  PubMed  Google Scholar 

  52. Triponez F, Goudet P, Dosseh D et al (2006) Is surgery beneficial for MEN1 patients with small (< or = 2 cm), non-functioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 30:654–662, discussion 663–664

    Article  PubMed  Google Scholar 

  53. Gagner M (1996) Early experience with laparoscopic resections of islet cell tumors. Surgery 120:1051–1054

    Article  PubMed  CAS  Google Scholar 

  54. Langer P, Bartsch DK, Fendrich V, Kann PH, Rothmund M, Zielke A (2005) Minimal-invasive operative treatment of organic hyperinsulinism. Dtsch Med Wochenschr 130:508–513

    Article  PubMed  Google Scholar 

  55. Fernandez-Cruz L, Cesar-Borges G (2006) Laparoscopic strategies for resection of insulinomas. J Gastrointest Surg 10:752–760

    Article  PubMed  Google Scholar 

  56. Carrere N et al (2007) Spleen-preserving distal pancreatectomy with excision of splenic artery and vein: a case-matched comparison with conventional distal pancreatectomy with splenectomy. World J Surg 31:375–382

    Article  PubMed  Google Scholar 

  57. Akerström G, Hellman P, Hessman O (2005) Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 19:717–728

    Article  Google Scholar 

  58. Akerström G, Hellman P, Hessman O (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169

    Article  PubMed  Google Scholar 

  59. Habbe N, Fendrich V, Bartsch DK (2010) Solitary versus multiple carcinoid tumors of the ileum: a clinical analysis of 87 cases. Langenbecks Arch Surg 395:1179–1197

    Article  Google Scholar 

  60. Gulec SA, Mountcastle TS, Frey D, Cundiff JD, Mathews E, Anthony L, O'Leary JP, Boudreaux JP (2002) Cytoreductive surgery in patients with advanced-stage carcinoid tumors. Am Surg 68:667–671, discussion 671–672

    PubMed  Google Scholar 

  61. Eriksson B, Klöppel G, Krenning E, Ahlman H, Plöckinger U, Wiedenmann B, Arnold R, Auernhammer C, Körner M, Rindi G, Frascati Consensus Conference Participants (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors—well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87:8–19

    Article  PubMed  CAS  Google Scholar 

  62. Arnold R, Rinke A, Klose KJ et al (2005) Octreotide versus octreotide plus interferon-ά in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol 3:761–771

    Article  PubMed  CAS  Google Scholar 

  63. Ohrvall U, Eriksson B, Juhlin C, Karacagil S, Rastad J, Hellman P, Akerström G (2000) Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 24:1402–1408

    Article  PubMed  CAS  Google Scholar 

  64. Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, PROMID Study Group (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27:4656–4663

    Article  PubMed  CAS  Google Scholar 

  65. Makridis C, Rastad J, Oberg K, Akerström G (1996) Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg 20:900–906, discussion 907

    Article  PubMed  CAS  Google Scholar 

  66. Sarmiento JM et al (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197:29–37

    Article  PubMed  Google Scholar 

  67. Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–785

    Article  PubMed  Google Scholar 

  68. Dousset B, Saint-Marc O, Pitre J et al (1996) Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 20:908–914

    Article  PubMed  CAS  Google Scholar 

  69. Que FG, Nagorny DM, Batts KP et al (1995) Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169:36–42

    Article  PubMed  CAS  Google Scholar 

  70. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA (1998) Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187:88–192

    Article  PubMed  CAS  Google Scholar 

  71. Chamberlain RS, Canes D, Brown KT et al (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190:432–435

    Article  PubMed  CAS  Google Scholar 

  72. Nave H, Mossinger E, Feist H et al (2001) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129:170–175

    Article  PubMed  CAS  Google Scholar 

  73. Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Lévy P, Vilgrain V, Ruszniewski P, Belghiti J (2008) Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Ann Surg 247:659–665

    Article  PubMed  Google Scholar 

  74. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13, 715 carcinoid tumours. Cancer 97:934–959

    Article  PubMed  Google Scholar 

  75. Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE (2009) Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 72:517–528

    Article  PubMed  Google Scholar 

  76. Pascher A, Klupp J, Neuhaus P (2005) Transplantation in the management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol 19:637–648

    Article  PubMed  Google Scholar 

  77. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, Lang H, Klempnauer J, Manns MP, Boeker KH (2002) Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumours. Transplantation 73:386–394

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Surgery, Philipps University Marburg, Baldingerstraße, 35043, Marburg, Germany

    Volker Fendrich & Detlef K. Bartsch

Authors
  1. Volker Fendrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Detlef K. Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Volker Fendrich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fendrich, V., Bartsch, D.K. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg 396, 299–311 (2011). https://doi.org/10.1007/s00423-011-0741-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-011-0741-7

Keywords

Search

Navigation